Active, Not Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
NCT05262023
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- John Hopkins University Baltimore, Maryland, United States
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
- University of Antwerp Antwerp, Belgium